Back to Journals » OncoTargets and Therapy » Volume 7

Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance

Total article views   Abstract views HTML views PDF downloads Totals
10,666 Dovepress* 7,816 1,212+ 1,688 9,028
PubMed Central* 7 1,631 450 1,638
Totals 7,823 2,843 2,138 10,666
*Since 16 January 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 3 3

View citations on PubMed Central and Google Scholar